The FDA lowered the maximum dose of the antidepressant citalopram hydrobromide (Celexa) from 60 mg per day to 40 mg per day, after concerns that higher doses of the medication increase the risk for cardiac arrhythmia without offering therapeutic benefits.
While it is true that lower serum ethinyl estradiol and progestin levels have been found in women using combination OCs and antibiotics, these women remain well within the therapeutic window.
How concerned should clinicians be about serotonin syndrome when prescribing a triptan with a selective serotonin reuptake inhibitor (SSRI)?
Is it possible to have a geriatric patient in serious delirium while all labs and urinalysis are within normal limits?
What is the appropriate workup in an otherwise healthy woman aged 75 years with new-onset hair loss?
Before prescribing medications to control diabetes, clinicians should consider potential adverse events and drug interactions.
Interim findings from an epidemiological study involving 193,099 patients with diabetes showed that using pioglitazone longer than one year increased patients’ risk for bladder cancer.
Clinicians should not administer methylene blue or linezolid, two reversible monoamine oxidase inhibitors (MOAIs), to patients taking selective serotonin reuptake inhibitors (SSRIs) due to risk for serious central nervous system reactions.
